摘要
The design of innovative drug nanocarriers with high encapsulation efficiency for targeted therapy remains a pivotal focus in biomedical research. Herein, we employed a combination of Friedel–Crafts crosslinking polymerization and N , N ′-dicyclohexylcarbodiimide/4-dimethylaminopyridine-mediated esterification to synthesize hyaluronic acid-decorated hollow nanocapsules (HA-HNs) for the active-targeted delivery of paclitaxel (PTX) to breast cancer cells. HA-HNs exhibited uniform hollow spheres with a distinctive sea-urchin-like morphology, characterized by an average external diameter of ~196 nm. Structural analysis revealed a hierarchical porous architecture featuring abundant micropores and mesopores, with a specific surface area of 558 m 2 /g and a pore size distribution primarily within the 3–5 nm range. The HA-HNs demonstrated a high drug entrapment efficiency of up to 45.83%. In vitro drug release studies indicated that cumulative PTX release was significantly restricted under neutral pH conditions, whereas accelerated release occurred under acidic conditions, confirming the pH-responsivity of PTX@HA-HNs. Moreover, PTX@HA-HNs exhibited significantly higher cytotoxicity against MCF-7 cells compared to non-targeted PTX@HNs, likely due to enhanced cellular internalization mediated by CD44 receptor binding. These results highlight the potential of HA-HNs as promising nanocarriers for targeted drug delivery in cancer therapy. Graphical At pH 7.4, hyaluronic acid-decorated hollow nanocapsules dissociated carboxyl groups form a hydrophilic shell, hindering PTX release. At pH 5.5, carboxyl protonation induces hyaluronic acid conformational shift, promoting PTX release.
危险品化学品经营许可证(带存储)